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Abstract
Sulfur, after calcium and phosphorus, is the most abundant mineral element found in our body. It
is available to us in our diets, derived almost exclusively from proteins, and yet only 2 of the 20
amino acids normally present in proteins contains sulfur. One of these amino acids, methionine,
cannot be synthesized by our bodies and therefore has to be supplied by the diet. Cysteine, another
sulfur containing amino acid, and a large number of key metabolic intermediates essential for life,
are synthesized by us, but the process requires a steady supply of sulfur.
Proteins contain between 3 and 6% of sulfur amino acids. A very small percentage of sulfur comes
in the form of inorganic sulfates and other forms of organic sulfur present in foods such as garlic,
onion, broccoli, etc.
The minimal requirements (RDA) for all the essential amino acids have always been estimated in
terms of their ability to maintain a nitrogen balance. This method asses amino acid requirements
for protein synthesis, only one of the pathways that methionine follows after ingestion. To
adequately evaluate the RDA for methionine, one should perform, together with a nitrogen balance
a sulfur balance, something never done, neither in humans nor animals.
With this in mind we decided to evaluate the dietary intake of sulfur (as sulfur amino acids) in a
random population and perform sulfur balance studies in a limited number of human volunteers.
Initially this was done to try and gain some information on the possible mode of action of a variety
of sulfur containing compounds (chondroitin sulfate, glucosamine sulfate, and others, ) used as
dietary supplements to treat diseases of the joints. Out of this study came information that
suggested that a significant proportion of the population that included disproportionally the aged,
may not be receiving sufficient sulfur and that these dietary supplements, were very likely exhibiting
their pharmacological actions by supplying inorganic sulfur.
Introduction
Because of the much larger implications of sulfur metab-
olism, and the role that this element plays in the synthesis
of a very large number of key metabolic intermediates,
such as glutathione, we decided to extend this review to
include a broad scope of overlapping metabolic pathways
that can be affected by insufficient or marginal intake of
sulfur. The hope is that such a review will encourage fur-
ther research into this very important and most often
neglected area of metabolism. This includes the potential
to affect the initiation and progression of a large number
of anomalies presenting inflammatory and degenerative
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changes as well as those associated with normal aging and
the wasting aspects of a large number of pathologies.
Sulfur containing metabolites, of which glutathione is a
key exponent, merge in their functioning with many other
compounds that play a major role in mechanisms which
are receiving tremendous interests as parts of conven-
tional and complementary medical care. These include
the n-3 and n-6 polyunsaturated fatty acids, minerals such
as Selenium, Zinc, Copper and Magnesium, vitamins E
and C, antioxidants such as the proanthocyanidins and
lipoic acid, many of which are involved in the synthesis of
prostaglandins and in the antioxidant cascade. More and
more evidence is accumulating and focusing on the coop-
erative role that glutathione and other sulfur metabolites
play in the homeostatic control of these fundamental
mechanisms.
Metabolism of sulfur containing amino acids
Methionine and cysteine are both required for protein
synthesis by simple-stomached mammals and avian spe-
cies [1]. For optimal growth, diets must provide these two
amino acids, or methionine alone. The physiological
requirements for cysteine can be met by dietary cysteine or
by an excess of dietary methionine. The molar efficiency
of trans-sulfuration, i.e. methionine sulfur converted to
cysteine sulfur, is 100%. Cysteine can reduce the require-
ments of dietary methionine even though no cysteine is
converted to methionine in higher organisms by sparing
its utilization for essential processes. From the standpoint
of the diet, methionine alone is capable of providing all
the necessary body sulfur, with the exception of the two
sulfur-containing vitamins, thiamin and biotin.
In 1989 a subcommittee of the United States Food and
Nutrition Board, National Research Council, issued its last
update on recommended dietary allowances (RDA) for
protein and amino acids (These recommendations rely on
N balance studies performed many years ago [2-4]. The
RDA for methionine (combined with cysteine) for adults
has been set at 14 mg/Kg of body weight per day. There-
fore a person weighing 70 Kg, independent of age or sex,
requires the consumption of around 1.1 g (0.9 mMoles)
of methionine/cysteine per day. When Rose proposed
these amounts he suggested that a "safe intake" should be
twice that amount or 2.0 g/day, probably acknowledging
that his studies had been done on limited numbers of
individuals, usually 3–6 for each amino acid.
These requirements of man for methionine, and the spar-
ing effects of cysteine, determined in young healthy vol-
unteers in 1955 by Rose et al are still accepted today, in
spite of indications that they may not represent universal
values [5]. Tuttle et al [6] feeding purified amino acid diets
containing variable amounts of methionine to older indi-
viduals at the VA Hospital in Los Angeles/UCLA estab-
lished values significantly higher than those previously
established by Rose in young college students. They all
needed more than 2.1 g/day, with some subjects requiring
up to 3.0 g/day to remain in positive nitrogen balance.
Although Fukagawa et al [7] were not able to confirm such
differences using amino acid oxidation, rather that N-bal-
ance as criteria; they agreed that further studies were
required. Neither their approaches, which relies on the
production of isotope enriched CO2, nor the nitrogen
balance studies take into account the unique role of the
SAA (sulfur amino acids), to provide S for sulfation. Fuller
and Garlick [8] who reviewed the subject in detail con-
cluded that, both for men and women amino acid
requirements appear underestimated.
In light of these concerns, particularly as it relates to the
unique role of the SAA in providing sulfates for GAG (gly-
cosaminoglycans) synthesis, it seems essential to deter-
mine if the needs for sulfur are being met, in particular as
it relates to GAG and GSH (glutathione) in cartilage. One
could predict that GAG synthesis may not fare well during
marginal intakes, and that a preference will be given to the
synthesis of proteins and essential metabolic intermedi-
ates like CoA, SAM (S-Adenosyl-L-Methionine), GSH, etc.
in the brain and other fundamental organs. Unfortunately
no studies have been performed to address this very
important question.
Studies in humans are not easy to perform, are costly and
subject to many variables. In other species, there appears
to be more information, particularly in poultry or cattle,
where growth stimulation represents a significant eco-
nomic advantage. It should be noted that poultry diets are
always supplemented with methionine/cysteine to
enhance growth [9,10].
Factors that can reduce the availability of methionine/
cysteine
Sulfation is a major pathway for detoxificication of phar-
macological agents by the liver. As already mentioned,
certain drugs that play a key role in the treatment of carti-
lage anomalies, such as acetaminophen require sulfate for
their excretion. Acetaminophen is given in large doses to
alleviate pain, and doses of up to 4 gm/day are recom-
mended in the label, but often more is consumed. Thirty
five % is excreted conjugated with sulfate and 3% conju-
gated with cysteine [11]. The rest is excreted conjugated
with glucuronic acid, incidentally also one of the major
components of GAG.
Methionine or cysteine (0.5%) added to the diet can over-
come the severe methionine deficiency induced in rats by
the addition of 1% acetaminophen, (an equivalent to the
4 gm/day to a human dose) [12]. It is interesting to noteNutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
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that D- as well as L-methionine could restore growth,
implying that depletion of sulfur was the primary defect
and not one related to protein synthesis.
Most important is that hepatic concentrations of active
sulfate, in the form of PAPS (adenosine 3'-phosphate 5'-
phosphosulftate) a key metabolic precursor of GAG was
also decreased and could be restored to normal by supple-
mentation with methionine [13]. Urinary sulfate excre-
tion was reduced up to 95% by feeding low-methionine
diets to rats, and a 60% decrease in liver methionine was
observed, [14]. Depending on the degree of depletion res-
toration of normal sulfate excretion and levels of liver glu-
tathione could be achieved during supplementation.
Inorganic sulfate was not as effective in restoring PAPS lev-
els as methionine (Fig 1).
In rats exposed to a deficient intake of sulfur to study sul-
fation of acetaminophen for purpose of biodegradation
alterations in PAPS homeostasis were observed [15]. Con-
comitantly these animals eliminated acetaminophen
from blood at a slower rate and converted it to a toxic
thioether intermediate. Reduced sulfation appears to be
caused by decreased availability of inorganic sulfate for
PAPS synthesis.
Glutathione (GSH) a key metabolite and storage form for 
sulfur
Sulfur amino acids contribute substantially to the mainte-
nance and integrity of the cellular systems by influencing
cellular redox state and the capacity to detoxify toxic com-
pounds, free radicals and reactive oxygen species [16].
Cysteine and methionine are not stored in the body. Any
dietary excess is readily oxidized to sulfate, excreted in the
urine (or reabsorbed depending on dietary levels) or
stored in the form of glutathione (GSH). Even in extreme
situations, such as when tryptophane deficiency leads to a
general catabolic effect, the organism tries to spare the loss
of sulfur by continuing to store any available sulfur as
GSH in the liver [17]. The availability of cysteine appears
to be the rate limiting factor for synthesis of GSH. GSH
values are subnormal in a large number of wasting dis-
eases and following certain medications leading fre-
quently to poor survival [18,19]. By supplying SAA many
of these changes can be reversed. In the brain, which is
usually the most spared organ during nutrient deficien-
cies, GSH concentration declines in order to maintain
adequate levels of cysteine. This loss of GSH impairs anti-
oxidant defenses. The active form of glutathione is the
reduced form, GSH, while the inactive form GSSG, has to
be converted to GSH. The usual ratio of GSH:GSSG in tis-
sues is around 100:1. Cartilage, less essential for survival,
may not fare well under conditions of sulfur deprivation,
explaining why dietary supplements containing sulfur
(chondroitin sulfate, glucosamine sulfate, MSM (Methyl-
sulfonylmethane), etc.) may be of benefit in the treatment
of joint diseases [20]. Neither GSH nor GAG synthesis
have been investigated in this context.
Even sulfurated water hydrotherapy, many times accom-
panied by the ingestion of such waters, and considered an
empirical treatment for a variety of diseases, has been
shown to involve the GSH related antioxidant cascade
[21,22]. The relationship of diet, age and other physiolog-
ical parameters to blood and tissue concentrations of GSH
are well documented [23-26]. Since all the dietary supple-
ments investigated containing sulfate, including MSM
[27] are readily metabolized prior or shortly after absorp-
tion to sulfate or small molecular weight intermediates,
they should be able to spare losses of GSH associated with
dietary deficiencies, increased utilization due to disease or
altered immune function.
Reactive oxygen species (ROS) are generated during nor-
mal cellular activity and may exist in excess in some
pathophysiological conditions, such as inflammation or
preperfusion injury. These molecules oxidize a variety of
cellular constituents, but sulfur-containing amino acid
residues are especially susceptible [28]. Therefore explor-
ing fundamental aspects of sulfur metabolism such as the
regulation of cell function by methionine oxidation and
reduction and the antioxidant effects of sulfur-containing
amino acids [29] may help elucidate the mechanism by
which the dietary supplements in question work.
Simplified diagram that depicts the relationships between  SAA, GAG synthesis, storage of cysteine as glutathione, pro- tein synthesis and nitrogen metabolism Figure 1
Simplified diagram that depicts the relationships between 
SAA, GAG synthesis, storage of cysteine as glutathione, pro-
tein synthesis and nitrogen metabolism.Nutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
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Glutathione: its protective role against oxidative and free 
radical damage and its potential to enhance the immune 
function
The manner in which cells and tissues respond to varia-
tions in SAA intake is constrained by the characteristics of
the key enzymes in the metabolic pathways involved [30].
At low intracellular concentrations of methionine,
remethylation of the metabolic product is favored over
transsulfuration, and methionine is conserved. With
increasing methionine intake, the transsulfuration path-
way, which provides a substrate for GSH synthesis, is
increased.
Thus, under conditions of low SAA intake, protein synthe-
sis will be maintained, and synthesis of sulfate and GSH
will be curtailed. Changes in the availability of GSH are
likely to influence in a negative fashion the function of the
immune system and of the antioxidant defense mecha-
nisms.
High dietary intakes methionine (5–6 g/day) on the other
hand have been shown to raise plasma levels of homo-
cysteine, despite adequate intakes of B vitamins [31-33].
This raises some concern as one does not want to activate
the immune system at the cost of enhancing monocyte
adherence to endothelial cells.
As discussed earlier GSH is influenced by dietary SAA
intake. In an isotopic study in rats, when diets with vari-
ous SAA contents were fed at adequate levels, 7 molecules
of S were incorporated into GSH for every 10 incorporated
into protein [34]. At inadequate levels of intake the ratio
fell to <3:10. This response to a low intake of SAA is causes
antioxidant defenses to become compromised.
A reduction in the levels of GSH, and consequently of
antioxidant defenses, may increase the risk of damage to
the host via transcription factor activation leading to up-
regulation of proinflammatory cytokines, such as nuclear
transcription factors and activator proteins, induced in
turn by agents such as hydrogen peroxide, mitogens, bac-
teria, viruses, and UV and ionizing radiation.
Oxidant damage to cells will give rise to a cascade of
proinflammatory effects by the production of lipid perox-
ides. Even though some of these effects are biphasic in
nature as it relates to levels of SAA, it is generally accepted
that GSH and the associated antioxidant activity exerts an
immune enhancing effect by activating transcription fac-
tors that are strongly associated with cell proliferation as
well as a parallel an anti-inflammatory effect as described
earlier.
Further knowledge of these metabolic processes, at other
levels beyond the availability of substrate, will be neces-
sary for us to be able to modulate with more accuracy
these events to the benefit of the whole organism.
Regulation of prostaglandin biosynthesis by glutathione
Prostaglandins (PGs) are very well known to play an
important role in a variety of normal body functions as
well in key metabolic steps associated with many of the
events associated with inflammation.
PGs are synthesized from free arachidonic acid via two
isoforms of cyclooxygenase (COX, also referred to as
PGH2 synthetase). Although the availability of arachi-
donic acid has been actively investigated as a major meta-
bolic factor controlling PG production, it is clear that
other cellular cofactors may also regulate PG biosynthesis.
PGH synthetase has two activities, the cyclooxygenase
activity which introduces the 5-membered ring into the
PUFA (polyunsaturated fatty acid), and another which
introduces an endoperoxide and a hydroperoxide into the
PUFA. The peroxidase activity reduces the hydroperoxide
into a hydroxyl group using GSH as a source of reducing
equivalents.
The observation that both the constitutive and the
mitogen inducible isoforms of prostaglandin H2 syn-
thetase are markedly affected by GSH and GSH peroxidase
[35], has catalyzed significant interest in connection with
this process. The sites of action of GSH and GSH peroxi-
dase on the metabolic pathway in question is shown in
Fig 2.
Studies by Margalit et al [36] has provided clear evidence
in mice that elevated levels of GSH inhibit PG production,
and most likely exhibit its anti-inflammatory effects in a
urate crystal induced model via this mechanism. This
attenuation of PG synthesis in vivo sheds light on another
potential benefit associated with increased SAA intake and
adequate levels of tissue GSH. From the practical point of
view, it raises the possibility that a satisfactory intake of
SAA combined with PUFA may prove of significant bene-
fit to individuals suffering from a variety of joint anoma-
lies associated with inflammation.
The question of how in the presence of adequate PUFA
precursors the constitutive and inducible forms of pros-
taglandin H synthetase can be induced to generate the
appropriate forms of prostaglandin required to maintain
tissue homeostasis will rely on further understanding of
the co-factors and feedback mechanisms involved.
Until these fundamental questions are answered, the best
we can do is to continue to reduce the ratio of omega 6/
omega 3 in our dietary supply of PUFA (which currently is
around 10.0 compared to 12.0 just a few years ago) byNutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
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increasing consumption of fish and certain plant oils, to
what is considered an ideal ratio of 2.3/1.0 [37].
Metabolic studies exploring the relationship of dietary 
sulfur intake to urinary excretion of inorganic sulfate
The lack of available data on the relationship of dietary
supplements, such as chondroitin sulfate and its ana-
logues, to dietary intake of sulfur and to any possible rela-
tionship encouraged us to contemplate a series of human
metabolic/balance studies that would relate intake of pro-
teins, dietary supplements containing sulfur and SAA to
sulfate excretion.
Our preliminary studies were presented at the American
College of Clinical Nutrition, American College of Rheu-
matology (2001) and subsequently published [20]. These
studies, even though limited in scope, provide further evi-
dence for the ready conversion of sulfur in dietary supple-
ments into inorganic sulfate. The retention of sulfur from
SAA or from the dietary supplements administered during
the ingestion of low or marginal levels of protein as com-
pared to the enhanced excretion during higher levels of
intake provided valuable clues (Fig. 3). It would appear
from our findings that the minimum adequate intake val-
ues determined in a VA setting in older people by Tuttle et
al [6] may closer to being accurate than those currently
accepted as the RDA.
Our studies were performed in normal volunteers (ages
35–70). Sulfate, free and esterified were measured by a
modification of the nephelometric method of Berglund
and Sorbo [38] and urine creatinine using a kit (555-A)
from Sigma. Intake of SAA was evaluated with the aid of a
Nutritional Analysis Software (ESHA Research, version
7.6). L-methionine (Solgar) was purchased as dietary sup-
plements. A sustained release formulation of L-methio-
nine was specially prepared by Xcel Medical Pharmacy
(Woodland Hills, CA.).
Relationship between dietary intake of protein with or 
without Methionine or S-containing compounds and 
urinary excretion of free sulfate
Subjects were adapted to a particular level of dietary pro-
tein by starting them on their diets 24 hours in advance of
the actual test. Protein levels were incremented by the
addition of low-fat tuna, which is mostly protein, to the
basal diet. Figure 3 summarizes sulfur balance studies that
include L-methionine supplements.
Our findings (Fig 3) clearly demonstrate that S retention
occurs during the consumption of low levels of protein.
Intake of SAA as part of the basic diet (dark bar) are super- imposed by a 10 mmole supplement of methionine adminis- tered as a single dose on the morning of the experiment Figure 3
Intake of SAA as part of the basic diet (dark bar) are super-
imposed by a 10 mmole supplement of methionine adminis-
tered as a single dose on the morning of the experiment. The 
total height of the bar therefore represents intake of S in 
mmoles. In an adjacent bar is the amount of free sulfate 
excreted in the urine over a 24 hour period.
Enzymatic conversion of arachidonic acid (AA) to PGs and  the sites of inhibition by GSH and GSH peroxidase (GSSPx) Figure 2
Enzymatic conversion of arachidonic acid (AA) to PGs and 
the sites of inhibition by GSH and GSH peroxidase (GSSPx). 
(Adapted from Marglit et al. [36]).Nutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
Page 6 of 12
(page number not for citation purposes)
When less than 10 mmoles of sulfur derived from dietary
proteins are consumed, supplementing the diet with 10
mmoles of L-methionine was accompanied by retention
of this amino acid. At higher levels of dietary protein
intake, when the requirements of sulfur are presumably
met, essentially all the methionine added to the diet is
excreted in the urine.
The significant retention of methionine at low levels of
protein intake gave the first clues that our dietary supply
of sulfur could be borderline or even unsatisfactory for
many individuals.
Intake of SAA in a normal population: relationship to the 
RDA and to the potential loss of sulfate associated with 
drug metabolism
A generalized assessment of diet intake and quality is very
difficult to make because of obvious reasons. The hetero-
geneity of populations (cultural, socio-economic, ethnic,
geography, occupation, fast-food consumption, advertis-
ing, etc) all influence food intake. Nevertheless, it seemed
important for the purpose of this study to try and generate
a profile that would cover various segments of the popu-
lation, and relate the values obtained to the accepted RDA
for SAA and to the alternate higher requirements sug-
gested by others. To gain further insight we grouped the
various individuals evaluated into subgroups (Table 1).
Even though diets vary periodically we noticed that indi-
viduals tend to adopt certain repetitive patterns that in a
way facilitated the evaluation. Intake of SAA measured in
32 individuals ranged between 1.8 and 6.0 g/day (14 and
45 mmoles/day). For purposes of calculations the cysteine
and methionine were combined as SAA. In general the
ratio of cysteine/methionine is close to one for poultry
and red meat protein, and to 0.7 for fish. Dairy products
tend to have slightly higher levels of methionine and
starch rich foods slightly more cysteine. Eggs contain sig-
nificantly more cysteine. To estimate molar concentra-
tions a 1:1 ratio was employed. Some of the lower SAA
values recorded in our survey included individuals who
tended to be more health conscious and consume no red
meet and little animal protein, as well as those consuming
"fad diets". Many older people could turn out to be out-
right deficient (group X) independent of the criteria used
(Fig 4). Obviously these dietary estimates have to be con-
sidered very preliminary, but they are meant, at this time,
to attempt to shed some light on an area seldom explored.
The above figure compares the SAA intake in g/day to the
accepted RDA (1989), twice the RDA values accepted to
provide greater safety to a large population, and to values
arrived to for older individuals by thee VA study of Tuttle
et al. [6].
Also a column is included, in which the available SAA are
reduced by 0.9 g/day, equivalent to a SAA loss associated
with the intake of the standard higher recommended dose
of acetaminophen. As already noted, this drug, as well as
several others, is excreted in great part conjugated with
sulfate. Depending on which assumption for minimum
requirements are used, only those groups who emerge
above the cut-off lines would be receiving an adequate
amount of SAA. Using Tuttle et al estimates [6] (which
agree well with our current estimates) combined with the
estimated loss of sulfate due to acetaminophen conjuga-
tion, a large segment of the population, which include
those most vulnerable to OA, would appear to be sulfur
deficient or receiving marginal intakes.
At this time we cannot draw any solid conclusions from
these estimates. We know that renal re-absorption of sul-
fates increases during periods of deficiency [39] but not
how long such a sparing effect can hold. The values
obtained by Tuttle et al are derived from a limited selected
VA population. So are ours as well as those of Rose et al.
Until these studies are expanded to include simultaneous
S and N-Balance determinations and biosynthetic studies
in animals, and well controlled S-balance studies in
humans are performed we will not be able to clearly
answer this important question.
It should be pointed out that we could not find in the
recorded literature any studies that effectively measure
sulfur balance in human or other animals. All metabolic
studies in this connection, even those that focus on the
requirements for sulfur amino acids, study nitrogen bal-
ance but not sulfur balance. Essentially this means that
the role of sulfur amino acids has only been evaluated in
herms of protein synthesis, but never in terms of their
ability to contribute sulfur to so many important metabo-
lites. As part of our preliminary investigations we evalu-
ated the dietary intake of SAA, the urinary excretion of
inorganic sulfate and of creatinine by a 35 year old male
Table 1: Average sulfur amino acid intake associated with the 
consumption of a variety of typical diets.
Group SAA (g/day)
I High-protein 6.8
II High-protein low-calorie 5.0
III Oriental-American 4.8
IV Average balanced 4.3
VF a s t - f o o d 4 . 1
VI Dieter 3.5
VII Lacto-ovo-vegetarian 3.0
VIII "health conscious diet 2.6
IX Vegan 2.3
X elderly people (75 yr old) 1.8Nutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
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subject consuming a random balanced diet over a 3 day
period. Results are summarized in Fig 5.
The above figure emphasizes another aspect of the pro-
posed studies, the relationship between S and N excretion.
We did not include the ethereal sulfate (less than 5% of
total) since no medication was being consumed. Excre-
tion of creatinine over a 24 hour periods has for a long
time been related to muscle mass and used for metabolic
calculations. They are not useful for N- balance studies
since they do not follow protein intake [40]. On the other
hand it is clear that sulfate intake and excretion correlate
quite well. Free amino acids in general cannot be stored
and the SH moiety of cysteine, in particular, is readily oxi-
dized. Cysteine can be cytotoxic since the reactive thiol-
amine structure can combine with aldehydes such as pyri-
doxal, and can also chelate essential divalent cations. SAA
are used to replenish the stores of GSH, which can be con-
sidered a storage form for sulfur, and only when this goal
is met is the excess oxidized to sulfate.
The excretion of sulfate associated with the administra-
tion of methyl prednisolone is included to illustrate how
a catabolic event can affect sulfur loss (Fig 6). Since ster-
oids are frequently used by patients with joint diseases,
the large excretion of sulfate may, among other things,
interfere with PG synthesis and other important metabo-
lites such as GSH. This aspect of the catabolic effect of ster-
oids does not seem to have been explored.
Consumption of sparkling mineral water containing 0.5 g
of sulfate/liter (in this case San Pellegrino, one of the very
few mineral waters that contains sulfate ions) throughout
the day (2 liters containing approximately 10 mmoles)
was accompanied by quantitative excretion of sulfate
when dietary protein levels supplied 25 mmoles of SAA or
more per day (Fig 7).
These findings support the observation, sometimes dis-
puted, that inorganic sulfates are readily absorbed and
excreted in urine, in spite of the osmotic effects that they
Dietary intake of SAA (methionine plus cysteine) measured in various subgroups of a population Figure 4
Dietary intake of SAA (methionine plus cysteine) measured in various subgroups of a population. These were compared to sug-
gested requirements: the RDA (1989), 2× the RDA (Rose's safety margin) [4] and Tuttle et al [6] determined in older individu-
als. A solid bar is included at the right of each group, which represents the SAA intake reduced by 0.9 g/day, to account for the 
estimated loss of sulfur associated with the consumption of a standard dose of acetaminophen, excreted as a sulfated conju-
gate.Nutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
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can generate and which lead to their use as laxatives
[11,41]. In our case, steady administration of a dilute
solution may have facilitated absorption from the GI tract
and enhanced urinary excretion. Absorption in the small
intestine is estimated to reach 5 mmoles/day, and the
remainder is absorbed in the colon [41].
Levels of sulfates in drinking water vary considerably with
their source and location. A study in Ohio, evaluating sul-
fate concentrations in well waters consumed by farm ani-
mals, revealed values that ranged between 6 and 1,600 g/
liter. The water in our studies, San Pellegrino, from an Ital-
ian source is stated in the label to contain .535 g sulfate
ions per liter. We found experimentally that the batches
used did not vary more than 5% from the stated value.
Inorganic sulfates are only very minor components of our
diet. Some processed or enriched foods contain minute
amounts of sulfites as preservatives and certain additives
included in flour, for instance, (ferric sulfate) can contain
sulfate. Garlic, onions, and brussel sprouts contain signif-
icant amounts of sulfur. Feedstuffs fed to animals has
been investigated for their sulfur content in much more
detail than foods for humans, and ranges from 0.2% in
beet pulp to 1.2% in canola meal (on a dry weight basis)
have been observed. As noted earlier the levels of sulfur in
the diet can greatly affect the growth and health of live-
stock.
Protein and amino acid requirements of the elderly with 
special focus on sulfur containing amino acids
The estimated protein requirements, for all ages, as dis-
cussed earlier, has been based on nitrogen equilibrium
studies, and aided occasionally by functional indicators
such as immune function or muscle strength. Data from
various sources, suggests that the protein requirements for
nitrogen equilibrium in the elderly is greater than the 0.8
gm/kg body weight/day. Values of around 1.0 gm/Kg have
been suggested [42]. However because of methodological
difficulties the data does not allow for a very confident
prediction.
As pointed out by Young [43] our knowledge of the die-
tary requirements for older individuals are often limited
and contradictory, although significant efforts continue to
Twenty four hour urinary excretion of sulfate by individuals  consuming different amounts of protein combined with 10  mmoles of sulfate from a mineral water source, evenly dis- tributed through out the daytime hours, and compared to  control (case 1, basal diet: 17 mM dietary SAA, case 2, basal  diet: 26 mM SAA) Figure 7
Twenty four hour urinary excretion of sulfate by individuals 
consuming different amounts of protein combined with 10 
mmoles of sulfate from a mineral water source, evenly dis-
tributed through out the daytime hours, and compared to 
control (case 1, basal diet: 17 mM dietary SAA, case 2, basal 
diet: 26 mM SAA).
Urinary excretion of sulfates and creatinine during consump- tion of a standard diet, over a period of 48 hours Figure 5
Urinary excretion of sulfates and creatinine during consump-
tion of a standard diet, over a period of 48 hours.
Urinary excretion of free sulfate following a single oral dose  of methyl prednisolone (24 mg) followed by a second dose of  (20 mg) the following day, while ingesting a diet that supplied  19 mmoles of SAA/day Figure 6
Urinary excretion of free sulfate following a single oral dose 
of methyl prednisolone (24 mg) followed by a second dose of 
(20 mg) the following day, while ingesting a diet that supplied 
19 mmoles of SAA/day.Nutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
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be made to overcome this problem. There is a general con-
sensus that the protein requirements of this population
are underestimated and it was suggested that a total of
15% of the energy requirements of this population be
supplied by proteins. This would translate into an average
of around 75–85 g of protein/day. This amount of pro-
tein, would supply approximately 3.5 to 4.0 g of SAA per
day, which should more than meet all estimates for the
requirements of these amino acids. Unfortunately these
levels of protein intake are infrequently met by the older
segment of the population. The well established sarcope-
nia associated with older age seems to be associated in
part to a decline in protein and energy intake, caused by
changes in taste sensation, alterations in dentition, social
isolation, depression and economic factors. In addition to
the less than optimal food intake, older individuals
appear to substitute protein in preference to fat and carbo-
hydrate rich meals, which may again reflect changes in
taste [44]. The WHO recommendations for SAA intake of
13 mg/kg of body weight are in the same range as those
suggested by the RDA. There is a consensus that in dis-
eases and following trauma these values may be 2 or 3
times higher [45].
There is a growing body of data pointing out the potential
importance of oxidative stress and resulting changes in
redox state in numerous diseases, including sepsis,
chronic inflammation, cancer AIDS/HIV, and of course
aging. These observations warrant continued attention for
the potential supplementation role of SAA supplementa-
tion, in the form of additional protein or as has been
found useful, N-acetylcysteine in some particular circum-
stances. Because of the toxicity of cysteine, and possibly
even of methionine supplements given in excess, and the
intrinsic problems associated with an induced amino acid
imbalance, proteins rich in SAA have been considered as
supplements. Immunocal®, a purified milk fraction
enriched in whey protein is currently being used because
of its potential to augment antioxidant defenses and
improve immune function [46]. Twenty grams/day of
Immunocal significantly enhanced muscular performance
and lymphocyte GSH in a group of 20 young adults.
Although whey proteins contain significantly more
cysteine than casein (2.5% vs. 0.35) the total amount of
total SAA is less significantly different (5.2% vs. 3.2%).
Cost and availability become another key factor in reduc-
ing dietary protein intake in the aged as do perceived
intolerance to certain food groups, difficulty tearing and
chewing fibrous foods, as well as the fear of consuming
too much fat or cholesterol. Unfortunately eggs, which
have a amino acid profile considered as a standard against
which other proteins are compared, and which are
amongst the proteins with a higher SAA content and are
amongst the least expensive in terms of cost, are often not
included as major ingredients in the diets of older people.
The importance of dietary protein cannot be underesti-
mated in this population since inadequate protein intake
contributes, among other things, to a decrease in lung
reserve capacity, increased skin fragility, osteoporosis,
decreased immune function and muscle mass (sarcope-
nia), poor healing and longer recuperation from illness
[2,47].
Discussion
Glutathione (GSH)is the most abundant low molecular
weight thiol and form of storage of SH-. Animal and
human studies have demonstrated that adequate protein
nutrition is crucial for the maintenance of GSH homeos-
tasis [48]. Elevated levels of GSH inhibit prostaglandin
production by a direct interaction with COX enzymes, of
potential significance in the progression of inflammatory
or degenerative states [36]. It is of particular interest, as
discussed earlier that prostagandins synthesized from
PUFA and most of the non-steroidal anti-inflammatory
drugs share this same locus of involvement. It is also rele-
vant that some recent studies have found that on occa-
sions the pain reduction in OA associated with the
administration of chondroitin sulfate, a source of sulfur,
was found to be equivalent to that provided by NSAID.
The reasons for such unpredictable results, we suspect
could be associated with differences in levels of protein in
the diet, the better responders consuming higher amounts
of SAA. This hypothesis will have to be evaluated in future
clinical studies.
As discussed neither cysteine nor methionine are stored in
the body. Any dietary excess is readily oxidized to sulfate,
excreted in the urine (or reabsorbed depending on dietary
levels) or stored in the form of glutathione (GSH). Even
in extreme situations, such as when tryptophane defi-
ciency leads to a general catabolic effect, the organism
tries to spare the loss of sulfur by continuing to store any
available sulfur as GSH in the liver. GSH values are sub-
normal in a large number of wasting diseases and follow-
ing certain medications, and by supplying SAA many of
these changes can be reversed [49]. Whether dietary sup-
plements containing sulfur display similar effects has not
been evaluated systematically. Documented improve-
ments in OA and joint pains associated with sulfurated
water hydrotherapy, many times accompanied by the
simultaneous ingestion of such waters has also been
related to the GSH involvement in the antioxidant cas-
cade.
In spite of the apparent complexity associated with evalu-
ating the dietary intake of a population as a whole a pat-
tern seems to emerge, even when evaluating small groupsNutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
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of individuals. In milk and dairy products the methio-
nine/cysteine ratio is around 3/1. It is roughly the same in
fishes such as canned tuna, which we used as a source of
protein supplement in our studies, and in meats. In eggs,
soy beans and other plant products it is around 4/3. The
amount of protein in the various foods varies considera-
bly, and the amount of SAA fluctuates. Chicken, fish and
beef proteins contain an average of around 5% of SAA.
Dairy products, milk, cheese, etc, contain lower levels,
around 4%, primarily due to the lower content of SAA in
casein. The whey protein fraction, accounts for about 20%
of the milk proteins (rich in lactoglobulins) contains
more SAA, and is used therapeutically or as a dietary sup-
plement. Plant proteins, in addition to be present in lower
amounts, are relatively low in SAA, averaging below 4%.
The highest content of SAA is found in egg products, the
egg white containing around 8% of SAA.
Consequently the ratios observed in a dietary survey will
reflect the amounts of meats, eggs and plant products con-
sumed. The amounts of protein, as a % of the calories con-
sumed, is a major variable in the population. The more
weight conscious individuals, and often the ones in more
affluent societies, tend to consume less carbohydrate and
fats and more proteins. This is counterbalanced some
times by the tendency of many to consume less animal
products and therefore to include more carbohydrates. In
addition the desire to lose weight may reduce both calo-
ries and protein intake. Older people, at a time when OA
becomes more prevalent, decrease their food intake often
at the expense of proteins, frequently due to economic
concerns.
Most individuals fall in between the groups established
arbitrarily for the purpose of this study, but once a dietary
pattern is established deviations are much less than
expected. In our experimental studies, the levels of SAA
were predetermined and individuals placed on pre-
assigned diets containing known amounts of protein. This
is critical, since even though the amounts of SAA intake
closely reflects the rate of sulfate excretion, below a certain
level of intake tubular reabsorption of sulfates prevents
further loss. In rats, sulfate renal clearance was signifi-
cantly decreased in animals that received a low methio-
nine diet, a reflection of a sparing mechanism to retain
sulfate [39]. A major unanswered question is how the
overall caloric intake affects the requirements of sulfur
used for other than protein synthetic purposes, and how
long a sparing effect can continue during the prolonged
intake of a low protein diet.
Any excess of SAA is oxidized to inorganic sulfate and
excrete in the urine as neither organic nor inorganic
excesses of sulfur can be stored. The normal concentration
of sulfate in serum is around 3.5 mg/100 ml, roughly 5–
10% of that as ether sulfate and the rest as sulfate ions.
Sulfur is excreted in the urine as it exists in blood.
A deficiency of sulfur amino acids has been shown to
compromise glutathione synthesis to a greater extent than
protein synthesis in the presence and absence of inflam-
matory stimulus [34]. During an immune/inflammatory
response a combination of enhanced utilization of
cysteine for GSH synthesis and cell replication may be
what leadsto a depletion of cellular SAM.
In man serum fasting levels of inorganic sulfate were
shown to increase with age and exhibit a circadian
rhythm, probably associated with food intake. Genetic
defects in sulfate transport have been associated with con-
genital osteochondrodystrophies that may be lethal and
provide insights into sulfate transport and hormonal and
nutritional regulation [50]. Whereas low levels of dietary
protein led to hip joint displasia in mice and rats normal
levels inhibited the development of OA.
Even though under normal circumstances dietary inor-
ganic sulfate contributes very little to our sulfate pool, the
exogenous administration of small amounts of sulfate in
selected forms of delivery may be useful, since contrary to
what is still a common belief sulfate can be absorbed form
the GI tract [41,51]. Along these lines the possible benefi-
cial effects of inorganic sulfates in drinking water should
be evaluated. Certain sulfur containing thermal water
baths have been found to be of benefit, probably via
transdermal penetration or because of actual drinking of
such waters at health spas [21,52-55].
On the other hand it is important to recollect that sulfa-
tion is a major pathway for detoxification of pharmaco-
logical agents by the liver. Drugs such as acetaminophen,
so frequently used in the treatment of pain associated with
joint diseases, require large amounts of sulfate for their
excretion. Doses of up to 4 g/day are not infrequent.
Thirty five % is excreted conjugated with sulfate, 3% con-
jugated with cysteine [12] and the rest conjugated with
glucuronic acid, incidentally a major component of gly-
cosamino glycans (GAG) which are so critical for the
integrity of cartilage and other connective tissues.
Methionine or cysteine (0.5%) added to the diet can over-
come the severe methionine deficiency induced in rats by
the addition of 1% acetaminophen, an equivalent to the
4 g/day of the human dose. D- as well as L-methionine
were found to be equally effective, suggesting that deple-
tion of sulfur was at the root of the primary defect and that
it was unrelated to protein synthesis. It is well known that
N-acetyl-p-benzoquinoneimine, a toxic metabolite of
acetaminophen is detoxified by hepatic GSH. Rapid
administration of acetyl-cysteine to restore GSH levelsNutrition & Metabolism 2007, 4:24 http://www.nutritionandmetabolism.com/content/4/1/24
Page 11 of 12
(page number not for citation purposes)
remains the treatment of choice following acetami-
nophen poisoning. Hepatic concentrations of active sul-
fate, in the form of PAPS (adenosine-3'-phosphate 5'-
phosphosulfate) were also decreased and could be
restored to normal by supplementation with methionine
[13].
The effectiveness of D-methionine in this connection
brings back to mind the early studies of Rose who used
DL-methionine in his early balance studies which led to
the RDA recommendations, again suggesting a significant
role for the SAA, beyond that of protein synthesis. That
cysteine, sulfite and other sources of sulfates can serve as
precursors for GAG synthesis has been well established
[56-58]. Also restricting the availability of dietary sulfur in
rats (cysteine, sulfate) decreased the biotransformation of
acetaminophen, as a consequence of the absence of inor-
ganic sulfate for PAPS synthesis [13,15]. Consequently,
addition of a sulfur containing compound to medications
such as acetaminophen or catabolic agents such as the cor-
ticosteroids, may be a potential way to compensate for
sulfur loss.
A major question that arises in connection with dietary
supplements that provide organic forms of sulfur, is
whether the diet could account for differences in response
amongst individuals. It is possible that the individuals
that benefit mostly from these supplements are those that
consume inadequate amounts of protein or other sources
of dietary sulfate. A recent publication by Drogue [59,60],
who has extensively investigated the relationship of oxi-
dative stress and aging, has concluded that this event may
be in great part be associated with a deficit of cysteine and
to a suboptimal intake of SAA.
Finally it may be relevant to conclude this review with a
statement taken from Sir Stanley Davidson and Pass-
more's classic textbook of Human Nutrition and Dietetics
[61] who suggested that" it is not unlikely that some of the
effects of protein deficiency are in fact due to failure of sul-
fur containing intermediates or even to sulfur containing
polysaccharides. It is even possible that the ancient nos-
trum of 'brimstone and treacle' (sulfur and molasses) had
nutritional value unsuspected by modern knowledge".
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